Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies
Daniel Ré, Jérôme Barrière, Emmanuel Chamorey, Margaux Delforge, Lauris Gastaud, Emmanuel Petit, Axel Chaminade, Benjamin Verrière, Frédéric Peyrade
Abstract
Click to increase image sizeClick to decrease image size Disclosure statementNo potential conflict of interest was reported by the author(s).Author contributionsDrs Re, Barrière, Chamorey, and Peyrade had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: all authors. Acquisition, analysis, or interpretation of data: all authors. Drafting of the manuscript: Dr Re. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: Dr Chamorey. Administrative, technical, or material support: all authors. Supervision: Drs Re and Barrière.